EVON MEDICS LLC
Elkridge, MD · Medtech · Private
Portable digital device for automated chemosensory and sensorimotor testing to stage cognitive decline and predict Alzheimer's disease progression
- Grants
- $19M
- 24 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 1 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD) | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD) | $450,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD) | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for relapse preventionin patients with Opioid Use (OUD) | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder | $820,883 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD) | $1,247,784 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease | $2,641,180 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder | $859,103 | |
| Federal grant | Department of Health and Human Services · Phase II · The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR) | $330,680 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD) | $1,245,116 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD) | $50,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease | $98,280 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P) | $499,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P) | $499,999 | |
| Federal grant | Department of Health and Human Services · Phase II · The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR) | $55,000 | |
| Federal grant | Department of Health and Human Services · Phase II · The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR) | $1,318,829 | |
| Federal grant | Department of Health and Human Services · Phase II · The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR) | $1,318,829 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD) | $448,887 | |
| Federal grant | Department of Health and Human Services · Phase I · Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD) | $448,887 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P) | $1,349,130 | |
| Federal grant | Department of Health and Human Services · Phase II · The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR) | $1,219,088 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD) | $1,249,244 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P) | $1,280,870 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD) | $1,249,244 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 953 | SOMAVAC Medical Solutions, Inc. | — | $13M |
| 954 | Surgimatix, Inc. | — | $1.4M |
| 955 | Advion, Inc. | — | $6.5M |
| 956 | EVON MEDICS LLC | — | — |
| 957 | WHITE EAGLE SONIC TECHNOLOGIES, INC. | — | $2.8M |
| 958 | JB HEALTHTECH, INC. | — | — |
| 959 | MNT SMARTSOLUTIONS LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Olfactory Testing Systems And Methodsgranted
- Pain Treatment Apparatus and Methodsapplication
- Pain Treatment Apparatus And Methodsapplication
- Olfactory Testing Systems And Methodsapplication
- Olfactory Testing Systems And Methodsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.